Myocardial contrast echocardiography (MCE) is an ultrasound imaging te
chnique which promises to provide a safe, noninvasive means of assessi
ng myocardial perfusion. A contrast agent, consisting of a suspension
of air-filled microspheres, serves as an ultrasound tracer. When these
microspheres are injected intravascularly, the acoustic interface cre
ated between the blood and the microspheres enhances the reflected ult
rasound signals. Thus, the how pattern of the microspheres represent t
he actual blood flow patterns. This paper will review the field of con
trast echocardiography, its background and history, the development of
ultrasound contrast agents, and a variety of experimental as well as
clinical uses. Contrast echocardiography has been utilized in the card
iac catheterization laboratory for the assessment of ''risk area,'' as
sessment of collateral blood how and assessment of coronary blood rese
rve. In the operating room, contrast echo is utilized for the determin
ation of cardioplegic perfusion, assessment of graft patency and evalu
ation of valvular regurgitation. In the future, with the technical adv
ancement in ultrasound imaging and the active interest and growth in t
he field of myocardial perfusion imaging using contrast echocardiograp
hy, the ability to provide routine real-time perfusion imaging may bec
ome a reality.